The advantages of recombinant antibodies are clear. The ability to fully control antibody production, from sequence through to Ab/antigen binding, makes these reagents very attractive for research and diagnostic applications.
periostin antibody Antibody OCD also means that recombinant Abs are a more suitable choice for clinical applications where the rules and regulations surrounding use of animals are stringent. Furthermore, recombinant Abs are more reliable than polyclonal antibodies as the recombinant production process eliminates some of the common issues that can cause differences in results such as batch-to-batch variability and non-specific binding.
Introduction to Custom Antibody Production
Recombinant Ab production has a number of other benefits including higher and more consistent antibody titers compared to hybridoma production, lower cost through reduced labor and reagent costs, and a shorter time to produce the desired antibodies. Additionally, recombinant Abs can be produced as fragments (Fabs and scFv) rather than full-length antibodies which is useful for some applications as it reduces the risk of cross-reaction. This is particularly useful for detecting cell surface markers and cytokines where a full-length antibody would likely interfere with binding by other cell-surface molecules.
The recombinant production process also eliminates the need for hybridoma culture which can be challenging to maintain under stable conditions and can be prone to genetic drift, leading to loss of the original antibodies. Finally, recombinant Ab production is a more ethical alternative to hybridoma-based production as it does not require the immunization of animals. Furthermore, recombinant antibodies can be engineered to have additional functionalities such as isotype switching and conjugation sites to enable specific labeling of the antibody for detection or purification.